Traitement au long cours de la maladie thromboembolique veineuse : pour quels patients?

Abstract

During the initial phase of treatment of a venous thromboembolic episode, anticoagulant treatment should be maintained as long as the benefits of this treatment outweigh the risks, in particular
at the risk of hemorrhage. A minimum period of 3 months must be prescribed at the end of a proximal DVT or a
EP according to Afassps recommendations published in November 2009 (www.afssaps.fr). Beyond that, the optimal duration should be discussed according to the characteristics of venous thromboembolic disease (VTE) and the
patient. Three elements can be discussed: